Black and Latino Americans saw surges in health care insurance enrollment through the Affordable Care Act (ACA) between 2020 and 2022; Medicaid enrollment and spending is expected to slow in 2023; the Biden administration is preparing a national hepatitis C treatment plan.
A new HHS report showed significant jumps in health care insurance enrollment among Black and Latino Americans between 2020 and 2022 during open enrollment periods. In 2022—following improvements in Affordable Care Act Marketplace outreach and education and in American Rescue Plan premium tax credits—enrollment of Black and Latino consumers increased by 49% and 53%, respectively, compared with 2020. The HHS report also noted a 32% increase in enrollment of American Indian and Alaska Native consumers, 11% increase of White enrollees, and 6% increase of Asian American, Native Hawaiian, and Pacific Islander enrollees.
A brief by the Kaiser Family Foundation analyzed Medicaid enrollment and spending trends for fiscal year (FY) 2022 and FY 2023. Following a sharp increase in FY 2021, some state Medicaid agencies reported enrollment growth slowed in FY 2022 to 8.4% and is projected to decline by –0.4% in FY 2023. This projection is largely based on the assumption that public health emergency and related maintenance of eligibility requirements will end by mid-FY 2023, and greater declines in enrollment are anticipated in future years. For spending, some agencies expect total—federal and state—Medicaid spending to reach a peak growth rate of 12.5% in FY 2022 and slow to 4.2% in FY 2023. Further, state spending increased by 9.9% in FY 2022 but is projected to increase more sharply by 16.3% in FY 2023 if the fiscal relief expires mid-FY 2023.
The Biden administration is preparing a national hepatitis C treatment plan that would streamline testing and treatment as well as work with drugmakers to bring down treatment costs, which spiked during the COVID-19 pandemic, Roll Call reported. The plan would include almost all government agencies, including the CDC, FDA, Substance Abuse and Mental Health Services Administration, Indian Health Service, and Federal Bureau of Prisons. The Biden administration said it hopes to secure partial funding within 2022 for the initiative, which is not yet formally launched.
As Claims Denials Surge, AI and Data-Driven Insights Equip Clinicians, Hospitals to Fight Back
March 13th 2025As health care costs continue to rise and the burden of chronic disease grows, data-driven insights will be essential in shaping the future of patient care, according to experts from Komodo Health and SmarterDx.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen